ArticleAME case reports2025

Failure of the tyrosine kinase inhibitors osimertinib and erlotinib to manage a patient with EGFR-mutant lung adenocarcinoma: a case report.

Malik W Z Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.